A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2011
12/01/2011	US20110294792 Purine derivatives as kinase inhibitors
12/01/2011	US20110294761 Stem cell cultures
12/01/2011	US20110294752 Triterpene compositions and methods for use thereof
12/01/2011	US20110294749 Diaminopyrimidinecarboxamide derivative
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110293751 Composition for Treatment of Skin
12/01/2011	US20110293732 Nanoparticles made of amorphous cellulose
12/01/2011	US20110293694 Quantum unit of inheritance vector therapy method
12/01/2011	US20110293693 Quantum unit of inheritance vector therapy
12/01/2011	US20110293605 Antibody formulation
12/01/2011	US20110293603 Amino acid sequences directed against multitarget scavenger receptors and polypeptides
12/01/2011	US20110293585 Compositions and methods for treatment of lysosomal storage disorders
12/01/2011	US20110293579 Bi-specific fusion proteins
12/01/2011	US20110293549 Composition, method and kit for enhancing hair
12/01/2011	US20110293524 Methods and compositions for the regulation of lectin complement pathway (lcp)-associated complement activation in hyperglycemic myocardial damage
11/2011
11/30/2011	EP2390254A1 NOVEL PYRROLOÝ2,3-d¨PYRIMIDINE COMPOUND
11/30/2011	EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases
11/30/2011	EP2389937A1 Medicinal composition for improving brain function
11/30/2011	EP2389932A1 Compositions for use in genetic disorders comprising 4-phenyl-butyric acid and its salts
11/30/2011	EP2389366A1 Benzodiazepin-2-on derivatives
11/30/2011	EP2156833B1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/30/2011	EP1801231B1 Method of screening baff suppressor or inhibitor
11/30/2011	EP1702626B1 Screening method for gamma-secretase inhibitors
11/30/2011	EP1469859B1 Use of polyunsaturated ketones for the treatment of psoriasis
11/30/2011	EP1461347B1 2-o-(-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
11/30/2011	CN1903259B 一种丹皮药材的提取分离方法 One kind of Dan herbs extraction methods
11/30/2011	CN1861112B 芪参益气滴丸在制备抑制白蛋白外漏药物中的应用 Qishenyiqi drop pills in the preparation of albumin leakage suppression drug application
11/30/2011	CN102264765A 抗muc1抗体 Antibody anti muc1
11/30/2011	CN102264699A 新的亚苄基-吲哚啉酮及它们的医疗和诊断用途 New benzylidene - indolinone and their medical and diagnostic uses
11/30/2011	CN102264366A 含有芝麻素类和表没食子儿茶素没食子酸酯的组合物 Containing sesamin class and Epigallocatechin gallate compositions
11/30/2011	CN102260672A 抑制猪生长抑素受体2基因表达的siRNA Pigs suppression of gene expression of somatostatin receptor 2 siRNA
11/30/2011	CN102260340A 五味子蛋白及其制备方法和药物用途 Schisandra protein and its preparation method and drug use
11/30/2011	CN102258698A 一种治疗头晕的中药组合物 A treatment for dizziness herbal composition
11/30/2011	CN102258626A 中药复方藤黄霖、其制备方法及其应用 Chinese herbal compound Garcinia Lin, their preparation and their use
11/30/2011	CN102258552A 一种白芷饮片的制备方法 Method for preparing Angelica Pieces
11/30/2011	CN102258516A 13-甲氨基-18-硫代苦参碱化合物用于制备抗肝纤维化或其他组织器官纤维化药物的应用 13- A -18- thiosulfate amino compounds used in the preparation of matrine liver fibrosis or other tissue and organ fibrosis drug application
11/30/2011	CN102258457A Non-aqueous composition
11/30/2011	CN101972286B 蜘蛛香总黄酮的新用途 New uses for spider incense total flavonoids
11/30/2011	CN101961462B 一种抗鸽热应激的中药组合物及其应用 An anti-pigeon heat stress herbal composition and its application
11/30/2011	CN101837056B 一种改善气虚血瘀型胸痹的浴足泡腾片 A method for improving Qi and Blood washes effervescent Chest
11/30/2011	CN101638431B 能与NKp80 受体结合的多肽及其应用 With NKp80 receptor binding polypeptides and their Applications
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/30/2011	CN101491606B 一种桂枝茯苓微丸及其制备方法 An Guizhi Fuling pellets and its preparation method
11/30/2011	CN101407457B 含羧基取代的查耳酮类衍生物及制备方法和用途 Containing carboxy-substituted chalcone derivatives and preparation and use
11/30/2011	CN101152296B 一种能平静身心、促进睡眠的香熏精油及其用途 One kind of body and mind can be calm and promote sleep aromatherapy oils and their uses
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma
11/29/2011	US8067453 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
11/29/2011	US8067437 Beta-2-adrenoreceptor agonists
11/29/2011	US8067428 Platelet ADP receptor inhibitors
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067363 Compositions and methods for promoting lipid mobilization in humans
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2638985C Therapeutic agent containing .omega.-feline interferon for treating feline atopic dermatitis
11/29/2011	CA2579032C Use of an .delta.-amino acid as thymocyte growth agent
11/29/2011	CA2526022C Sulfotransferase inhibitor
11/29/2011	CA2507502C Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
11/29/2011	CA2494345C Combination of an aromatase inhibitor with a bisphosphonate
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/29/2011	CA2479786C Quinoline derivatives and their use as 5-ht6 ligands
11/29/2011	CA2479711C Formulation
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2462580C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs)
11/29/2011	CA2453843C Substituted 4-aminocyclohexanol derivatives
11/29/2011	CA2438524C Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
11/29/2011	CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/29/2011	CA2371226C 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
11/24/2011	WO2011146886A1 Processes for producing modulators of cystic fibrosis transmembrane conductance regulator
11/24/2011	WO2011146471A1 Treatment for altitudinal hypoxia
11/24/2011	WO2011145735A1 Thiazole derivative
11/24/2011	WO2011145718A1 Novel pyrrolo[2,3-d]pyrimidine compound
11/24/2011	WO2011145642A1 Pharmaceutical composition containing solifenacin
11/24/2011	WO2011145615A1 Nucleic acid for production of pluripotent stem cell
11/24/2011	WO2011145548A1 Crystals of di(arylamino)aryl compound
11/24/2011	WO2011145343A1 Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
11/24/2011	WO2011145340A1 Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
11/24/2011	WO2011145307A1 Adiponectin production accelerating composition
11/24/2011	WO2011144248A1 Composition for removing atheromatous plaque
11/24/2011	WO2009023160A8 Novel inhibitors of bacterial sortase enzymes and methods of using the same
11/24/2011	US20110289611 Rna sequence-specific mediators of rna interference
11/24/2011	US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof
11/24/2011	US20110288651 Supercritical Carbon-Dioxide Processed Biodegradable Polymer Nanocomposites
11/24/2011	US20110288163 Methods of using macrocyclic modulators of the ghrelin receptor
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288146 Directly compressible granular microcrystalline cellulose based, excipient, manufacturing process and use thereof
11/24/2011	US20110288135 Fast Dissolving Tablet
11/24/2011	US20110288122 Pharmaceutical Compositions and Administrations Thereof
11/24/2011	US20110288104 Beta-3 receptor ligands and their use in therapy
11/24/2011	US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011	US20110288082 Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase
11/24/2011	US20110288026 Electroprocessed Collagen and Tissue Engineering
11/24/2011	US20110288025 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
11/24/2011	US20110288011 Peptide therapeutic conjugates and uses thereof
11/24/2011	US20110288004 Viral Sequences and Uses Thereof

1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 1564